Merus (MRUS) Soars to New High on Genmab Merger at 41% Premium
We recently published 10 Stocks With 10-60% Upside. Merus NV (NASDAQ:MRUS) is one of the top performers on Monday. Shares of Merus NV soared to a new record high on Monday, as investors gobbled up shares following news that it was set to be acquired by Genmab AS at a 41-percent premium. In a statement, Genmab AS said that it entered into an agreement with Merus NV (NASDAQ:MRUS) for the acquisition of the latter, through its subsidiary, Purchaser, for $8 billion. Merus (MRUS) Soars to New High on Genmab ...